Interventional technology firm Medtronic is touting clinical results released at Heart Rhythm 2009, the annual meeting of the Heart Rhythm Society (HRS), that show that patients with the company's EnRhythm MRI-safe pacemaker experienced no complications during the exam.
The study results demonstrated that the EnRhythm MRI SureScan pacing system performs as intended during and after an MRI study. The data showed no MRI-related complications, no arrhythmias, and no asystole (absence of electrical activity in the heart) during MRI scans.
The trial involved 464 patients implanted with the device. Two hundred fifty-eight underwent MRI and 206 did not receive MRI. All patients were evaluated before and after the scan, at one week, and at one month after the MRI scan or control visit. There was no difference between the MRI group and the control group.
Medtronic released EnRhythm MRI SureScan in Europe last fall.
Related Reading
Medtronic progresses with Endurant trial, May 6, 2009
Medtronic brings Endeavor stent to Japan, March 30, 2009
Medtronic poses revision for CMS NCD, March 17, 2009
Medtronic completes stent safety study enrollment, February 2, 2009
Boston Scientific, Medtronic bury the hatchet, January 28, 2009
Copyright © 2009 AuntMinnie.com
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
